SKI Market

Indian Indices

Nifty

25,285.35 103.55
(0.41%)

Sensex

82,500.82 328.72
( 0.40%)

Bank Nifty

56,609.75 417.70
( 0.74%)

Nifty IT

35,609.05 -19.45
( -0.05%)

Global Indices

Nasdaq

45,502.84 -876.59
(-1.89%)

Dow Jones

6,574.01 -182.10
(-2.70%)

Hang Seng

48,192.70 -387.74
(-0.80%)

Nikkei 225

9,427.47 -81.93
(-0.86%)

Forex

USD-INR

88.81 0.04
(0.05%)

EUR-INR

103.01 -0.16
(-0.15%)

GBP-INR

118.58 -0.38
(-0.32%)

JPY-INR

0.58 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

223.7724493

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

44.28

15623.82

EPS(TTM)

Face Value()

Div & Yield %

46.42

0.27

Back

Jetking Infotrain consolidated net profit declines 77.08% in the June 2025 quarter

Aug 13,2025

Net profit of Jetking Infotrain declined 77.08% to Rs 0.80 crore in the quarter ended June 2025 as against Rs 3.49 crore during the previous quarter ended June 2024. Sales rose 25.77% to Rs 6.10 crore in the quarter ended June 2025 as against Rs 4.85 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	6.10	4.85	26
OPM %	2.46	-5.98	-
PBDT	1.46	4.08	-64
PBT	0.80	3.49	-77
NP	0.80	3.49	-77

25,285.35 103.55 (0.41%)

82,500.82 328.72 ( 0.40%)

56,609.75 417.70 ( 0.74%)

35,609.05 -19.45 ( -0.05%)

45,502.84 -876.59 (-1.89%)

6,574.01 -182.10 (-2.70%)

48,192.70 -387.74 (-0.80%)

9,427.47 -81.93 (-0.86%)

88.81 0.04 (0.05%)

103.01 -0.16 (-0.15%)

118.58 -0.38 (-0.32%)

0.58 0.00 (-0.12%)